David Scadden, Director at Magenta Therapeutics, Inc. (MGTA), bought 34,676 shares at $15.00 ($99K) on 2018-06-25, disclosed to the SEC on 2018-06-27.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 28,076 | $0 | 0.0% |
| 2 | $15.00 | 6,600 | $99K | 100.0% |
| Total | $2.86 avg | 34,676 | $99K | 100% |
| Filing → |
| AGIO | SELL | 2025-10-02 | $8K | — | Filing → |
| AGIO | SELL | 2025-08-29 | $8K | — | Filing → |
| AGIO | SELL | 2025-07-15 | $56K | — | Filing → |